DJ-1 modulates aggregation and pathogenesis in models of huntington's disease

Human Molecular Genetics

Volumn 23, Issue 3, 2014, Pages 755-766

  Sajjad, Muhammad U ^a   Green, Edward W ^b   Miller Fleming, Leonor ^b,c   Hands, Sarah ^a   Herrera, Federico ^c   Campesan, Susanna ^b   Khoshnan, Ali ^f   Outeiro, Tiago F ^c,d,e   Giorgini, Flaviano ^b   Wyttenbach, Andreas ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; HUNTINGTIN EXON 1; MUTANT PROTEIN; POLYGLUTAMINE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; DROSOPHILA; GENE OVEREXPRESSION; HUNTINGTON CHOREA; MOUSE; MOUSE MODEL; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ANIMALS; ASTROCYTES; BRAIN; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; DROSOPHILA; HUMANS; HUNTINGTON DISEASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS; OXIDATION-REDUCTION; PEPTIDES; YEASTS;

EID: 84892470940     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt466     Document Type: Article

References (50)

1. Sajjad, M.U., Samson, B. and Wyttenbach, A. (2010) Heat shock proteins: therapeutic drug targets for chronic neurodegeneration? Curr. Pharm. Biotechnol., 11, 198-215.
2. Nagai, Y., Fujikake, N., Popiel, H.A. and Wada, K. (2010) Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases. Curr. Pharm. Biotechnol., 11, 188-197.
3. Wyttenbach, A. (2004) Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J. Mol. Neurosci., 23, 69- 96.
4. Graf, P.C. and Jakob, U. (2002) Redox-regulated molecular chaperones. Cell. Mol. Life Sci., 59, 1624-1631.
5. Jakob, U., Muse, W., Eser, M. and Bardwell, J.C. (1999) Chaperone activity with a redox switch. Cell, 96, 341-352.
6. Lee, S.J., Kim, S.J., Kim, I.K., Ko, J., Jeong, C.S., Kim, G.H., Park, C., Kang, S.O., Suh, P.G., Lee, H.S. et al. (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem., 278, 44552-44559.
7. Shendelman, S., Jonason, A., Martinat, C., Leete, T. and Abeliovich, A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol., 2, e362.
8. Wilson, M.A. (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxidants Redox Signal., 15, 111-122.
9. Kahle, P.J., Waak, J. and Gasser, T. (2009) DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic. Biol. Med., 47, 1354-1361.
10. Meulener, M.C., Xu, K., Thomson, L., Ischiropoulos, H. and Bonini, N.M. (2006) Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidativedamage and aging. Proc. Natl. Acad. Sci.USA, 103, 12517-12522.
11. van der Brug, M. P., Blackinton, J., Chandran, J., Hao, L.Y., Lal, A., Mazan-Mamczarz, K., Martindale, J., Xie, C.,Ahmad,R., Thomas,K.J. et al. (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc.Natl. Acad Sci. USA, 105, 10244-10249.
12. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
13. Aron, L., Klein, P., Pham, T.T., Kramer, E.R., Wurst, W. and Klein, R. (2010) Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. PLoS Biol., 8, e1000349.
14. Waragai, M., Nakai, M., Wei, J., Fujita, M., Mizuno, H., Ho, G., Masliah, E., Akatsu, H., Yokochi, F. and Hashimoto,M.(2007) Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neurosci. Lett., 425, 18-22.
15. Waragai, M., Wei, J., Fujita, M., Nakai, M., Ho, G.J., Masliah, E., Akatsu, H., Yamada, T. and Hashimoto, M. (2006) Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem. Biophys. Res. Commun., 345, 967-972.
16. Yamashita, S., Mori, A., Kimura, E., Mita, S., Maeda, Y., Hirano, T. and Uchino, M. (2010) DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity. J. Neurochem., 113, 860-870.
17. Choi, J., Sullards, M.C., Olzmann, J.A., Rees, H.D., Weintraub, S.T., Bostwick, D.E., Gearing, M., Levey, A.I., Chin, L.S. and Li, L. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem., 281, 10816-10824.
18. Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA, 101, 9103-9108.
19. Blackinton, J., Lakshminarasimhan, M., Thomas, K.J., Ahmad, R., Greggio, E., Raza, A.S., Cookson, M.R. and Wilson, M.A. (2009) Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J. Biol. Chem., 284, 6476-6485.
20. Baulac, S., Lu, H., Strahle, J., Yang, T., Goldberg, M.S., Shen, J., Schlossmacher, M.G., Lemere, C.A., Lu, Q. and Xia, W. (2009) Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol. Neurodegener., 4, 12.
21. Miyazaki, S., Yanagida, T., Nunome, K., Ishikawa, S., Inden, M., Kitamura, Y., Nakagawa, S., Taira, T., Hirota, K., Niwa, M. et al. (2008) DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J. Neurochem., 105, 2418-2434.
22. Yamane, K., Kitamura, Y., Yanagida, T., Takata, K., Yanagisawa, D., Taniguchi, T., Taira, T. and Ariga, H. (2009) Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Int. J. Mol. Sci., 10, 4789-4804.
23. Ooe, H., Iguchi-Ariga, S.M. and Ariga, H. (2006) Establishment of specific antibodies that recognize C106-oxidized DJ-1. Neurosci. Lett., 404, 166- 169.
24. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. and Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci., 19, 3248-3257.
25. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
26. Wyttenbach, A., Swartz, J., Kita, H., Thykjaer, T., Carmichael, J., Bradley, J., Brown, R., Maxwell, M., Schapira, A., Orntoft, T.F. et al. (2001) Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum. Mol. Genet., 10, 1829-1845.
27. Yanagida, T., Tsushima, J., Kitamura, Y., Yanagisawa, D., Takata, K., Shibaike, T., Yamamoto, A., Taniguchi, T., Yasui, H., Taira, T. et al. (2009) Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid. Med. Cell. Longev., 2, 36-42.
28. Duennwald, M.L., Jagadish, S., Muchowski, P.J. and Lindquist, S. (2006) Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. USA, 103, 11045-11050.
29. Meriin, A.B., Zhang, X., Miliaras, N.B., Kazantsev, A., Chernoff, Y.O., McCaffery, J.M., Wendland, B. and Sherman, M.Y. (2003) Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis. Mol. Cell. Biol., 23, 7554-7565.
30. Skoneczna, A., Micialkiewicz, A. and Skoneczny, M. (2007) Saccharomyces cerevisiae Hsp31p, a stress response protein conferring protection against reactive oxygen species. Free Radic. Biol. Med., 42, 1409-1420.
31. Wilson, M.A., St Amour, C.V., Collins, J.L., Ringe, D. and Petsko, G.A. (2004) The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily. Proc. Natl. Acad. Sci.USA, 101, 1531-1536.
32. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
33. Hao, L.Y., Giasson, B.I. and Bonini, N.M. (2010) DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc. Natl. Acad. Sci. USA, 107, 9747-9752.
34. Meulener, M., Whitworth, A.J., Armstrong-Gold, C.E., Rizzu, P., Heutink, P., Wes, P.D., Pallanck, L.J. and Bonini, N.M. (2005) Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol., 15, 1572-1577.
35. Kerppola, T.K. (2006) Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol., 7, 449-456.
36. Herrera, F., Tenreiro, S., Miller-Fleming, L. and Outeiro, T.F. (2011) Visualization of cell-to-cell transmission of mutant huntingtin oligomers. PLoS Curr., 3, RRN1210.
37. Kinumi, T., Kimata, J., Taira, T., Ariga, H. and Niki, E. (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 317, 722-728.
38. Wilson, M.A., Collins, J.L., Hod, Y., Ringe, D. and Petsko, G.A. (2003) The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl. Acad. Sci. USA, 100, 9256-9261.
39. Hands, S., Sajjad, M.U., Newton, M.J. and Wyttenbach, A. (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J. Biol. Chem., 286, 44512-44520.
40. Zhou, W., Zhu, M., Wilson, M.A., Petsko, G.A. and Fink, A.L. (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol. Biol., 356, 1036-1048.
41. Blackinton, J., Kumaran, R., van der Brug, M. P., Ahmad, R., Olson, L., Galter, D., Lees, A., Bandopadhyay, R. and Cookson, M.R. (2009) Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neuroscience Lett., 452, 8-11.
42. Bandopadhyay, R., Kingsbury, A.E., Cookson, M.R., Reid, A.R., Evans, I.M., Hope, A.D., Pittman, A.M., Lashley, T., Canet-Aviles, R., Miller,D.W. et al. (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain, 127, 420-430.
43. Vargas, M.R. and Johnson, J.A. (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med., 11, e17.
44. Belanger, M. and Magistretti, P.J. (2009) The role of astroglia in neuroprotection. Dialogues Clin. Neurosci., 11, 281-295.
45. Hands, S.L., Mason, R., Sajjad, M.U., Giorgini, F. and Wyttenbach, A. (2010) Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease. Biochem. Soc. Trans., 38, 552-558.
46. Aiken, C.T., Tobin, A.J. and Schweitzer, E.S. (2004)Acell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis., 16, 546-555.
47. King, M.A., Hands, S., Hafiz, F., Mizushima, N., Tolkovsky, A.M. and Wyttenbach, A. (2008) Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol. Pharmacol., 73, 1052-1063.
48. Herrera, F. and Outeiro, T.F. (2012) Alpha-synuclein modifies huntingtin aggregation in living cells. FEBS Lett., 586, 7-12.
49. Gelperin, D.M., White, M.A., Wilkinson, M.L., Kon, Y., Kung, L.A., Wise, K.J., Lopez-Hoyo, N., Jiang, L., Piccirillo, S., Yu, H. et al. (2005) Biochemical and genetic analysis of the yeast proteome with a movableORF collection. Genes Dev., 19, 2816-2826.
50. Campesan, S., Green, E.W., Breda, C., Sathyasaikumar, K.V., Muchowski, P.J., Schwarcz, R., Kyriacou, C.P. and Giorgini, F. (2011) The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr. Biol., 21, 961-966.